WASHINGTON, Jan. 11 -- The U.S. Department of Health and Human Services National Institutes of Health announced that it expects to award a grant for the validation of molecular, cellular, and imaging markers for cancer detection. The agency description of the grant states: "The purpose of this Funding Opportunity Announcement (FOA) is to accelerate the pace of translation of NCI-supported methods/assays/technologies (referred to as "assays") to the clinic. Specifically, the focus of this FOA is  more